GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (NSE:CIPLA) » Definitions » Purchase Of Investment

Cipla (NSE:CIPLA) Purchase Of Investment : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 1995. Start your Free Trial

What is Cipla Purchase Of Investment?

Cipla's purchase of investment for the three months ended in Mar. 2025 was ₹0 Mil. It means Cipla spent ₹0 Mil on purchasing investments. Cipla's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Dec. 2024 ), Cipla spent the same money on purchasing investments in Mar. 2025 (₹0 Mil).

Cipla Purchase Of Investment Historical Data

The historical data trend for Cipla's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipla Purchase Of Investment Chart

Cipla Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16,617.00 -14,168.70 -13,508.20 -16,971.00 -21,996.40

Cipla Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cipla Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipla Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Cipla's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Cipla Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (NSE:CIPLA) » Definitions » Purchase Of Investment
Comparable Companies
NSE:TORNTPHARM BOM:543904 BOM:500124 BOM:500257 BOM:532321 NSE:DIVISLAB NSE:AUROPHARMA BOM:500488 NSE:ALKEM BOM:532296 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506
Traded in Other Exchanges
500087:India
Address
Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Website
https://www.cipla.com
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.

Cipla Headlines

No Headlines